AI craze stokes ‘bubble within a bubble,’ says GMO’s Jeremy Grantham
The U.S. stocks appear expensive after investor mania surrounding artificial-intelligence interrupted the bursting of an initial market bubble, according to GMO’s Jeremy Grantham.
New warning signs say that celebrating a Fed victory over inflation is premature
The U.S. economy reaccelerating or mildly contracting is more likely than a “soft landing.”
Homeowners scrambling for cash breathe new life into second-lien mortgage market
Second-lien mortgages have been getting a new lease on life as more borrowers tap their homes for cash two years since the Federal Reserve began...
Vail Resorts’ stock slips after results, guidance hurt by decline in visits, snowfall
Shares of Vail Resorts Inc. fell after hours on Monday, after the ski-resort operator cut its full-year profit outlook following a drop in skier visits...
Biden wants to eliminate origination fees for student loans and make some forgiveness tax-free
The White House is proposing tweaks to the student-loan program that could make the loans less costly for borrowers.
Here’s how Apple could uniquely leverage AI — and send its sagging stock higher
Apple could make it easier for users to engage with AI on their devices thanks to its tightly linked hardware and software ecosystems, says an...
Oracle’s stock is climbing, thanks to large new cloud deals, AI demand
Oracle Corp.’s stock initially climbed 8% in extended trading Monday after the company posted mixed results. The company’s board also declared a quarterly cash dividend...
How software investors should view the AI ‘tsunami’ as chip stocks outperform
Jefferies thinks software investors should stay choosy as they wait for the sector’s AI windfall to take shape.
Acadia Pharma’s stock falls 15% after failed drug trial
One of Acadia Pharma’s drugs failed to meet goals of a late-stage trial about a schizophrenia treatment.